MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Mitochondrial dysfunction"

  • 2023 International Congress

    To stimulate or not to stimulate? Bilateral subthalamic (STN) Deep Brain Stimulation (DBS) in cases of young-onset parkinsonism with mitochondrial dysfunction induced neurodegeneration.

    E. Efthymiou, B. Büchele, S. Mahendran, L. Stieglitz, C. Baumann, B. Balint (zurich, Switzerland)

    Objective: To describe two cases of young-onset parkinsonism (YOP; case 1 with mitochondrial membrane protein associated neurodegeneration (MPAN) due to a heterozygous mutation in C19orf12;…
  • 2022 International Congress

    A Pilot Feasibility Study of Medium Chain Triglyceride Nutritional Ketosis and Parkinson’s Disease

    A. Choi, M. Delgado, K. Chen, S. Chung, A. Courville, S. Turner, S. Yang, K. Airaghi, I. Dustin, P. Mcgurrin, M. Hallett, D. Ehrlich (Sun City, USA)

    Objective: To determine if nutritional ketosis supplemented by medium chain triglycerides (MCT) over the course of 2-3 weeks is acceptable and feasible in patients with…
  • 2022 International Congress

    Effectiveness of Combined tDCS and tNIRS on Motor Performance in Parkinson’s Disease – A Single Case Study

    N. Choudhary (Jodhpur, India)

    Objective: The aim of the current study was to evaluate the synergistic effects of combining transcranial near infrared light stimulation (tNIRS) and transcranial direct current stimulation…
  • 2022 International Congress

    Functional validation of a mitochondria-specific polygenic risk score in patient-based models for stratification of idiopathic Parkinson’s disease

    G. Arena, Z. Landoulsi, A. Vitali, S. Delcambre, P. Antony, I. Boussaad, L. Pavelka, M. Sharma, E. Glaab, D. Grossmann, A. Grünewald, P. May, R. Krüger (Esch-sur-Alzette, Luxembourg)

    Objective: The overall objective of this project is to gain essential knowledge on the contribution of genetic variability in nuclear-encoded mitochondrial proteins to idiopathic Parkinson’s…
  • 2022 International Congress

    Metabolic Biomarkers of Parkinson’s Disease in Peripheral Tissue

    L. Mischley, E. Shankland, S. Liu, S. Bhayana, D. Marcinek (Seattle, USA)

    Objective: The goal of this study was to use magnetic resonance spectroscopy (MRS) to test whether muscles of individuals with Parkinson’s disease (PD) possess a…
  • 2022 International Congress

    Effect of exercise on brain metabolism and energetics in PD

    C. Bevington, R. Jayde Williams, B. Pike, J. Mckenzie, J. Zhang, W. Luh, AJ. Stoessl, V. Sossi (Vancouver, Canada)

    Objective: To identity the effect of exercise on brain metabolism and energetics in PD using PET/MR imaging. Background: Aerobic exercise slows PD progression as reflected…
  • 2022 International Congress

    Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: TALISMAN study rationale and protocol

    J. Janssen Daalen, M. Meinders, B. Stunnenberg, H. Groenewoud, P. Ainslie, D. Thijssen, B. Bloem (Nijmegen, Netherlands)

    Objective: This is the first study that will assess the potential impact of hypoxia-based therapy in individuals with PD on respiratory parameters and PD symptoms.…
  • 2022 International Congress

    The overexpression of a-SYN leads to a differential process of mitophagy in neurons and atrocytes

    I. Lastres-Becker, S. Castro-Sánchez, I. Silva-Llanes, P. Teresak, JL. Lanciego, E. Sierra, P. Boya (Madrid, Spain)

    Objective: To determine the role of the different mitophagy pathways involved in PD, a key question that is still unresolved. We will investigate whether a-synuclein…
  • 2022 International Congress

    Mitochondrial and autophagy alteration in a new fatty acid hydroxylase-associated neurodegeneration (FAHN) model

    F. Mandik, S. Misera, Y. Kanana, B. Wilken, C. Klein, M. Vos (Luebeck, Germany)

    Objective: Establishing a FAHN Drosophila model to identify cellular disease mechanisms. Background: Fatty acid hydroxylase-associated neurodegeneration (FAHN) is an early-onset neurodegenerative disease that manifests brain…
  • 2022 International Congress

    Mutant WDR45 leads to altered ferroptosis in β-propeller protein-associated neurodegeneration

    S H. Diaw, C. Ganos, S. Zittel, K. Plötze-Martin, L. Kulikovskaja, A. Westenberger, M. Vos, A. Rakovic, M. Dulovic-Mahlow, K. Lohmann (Lübeck, Germany)

    Objective: To functionally characterize WDR45-mediated BPAN (Beta-propeller protein-associated neurodegeneration). Background: BPAN patients usually present with global developmental delay and autistic features in early childhood and…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 14
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley